(Q80616138)
Statements
A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia (English)
Donald C Goff
Nancy A Rigotti
Oliver Freudenreich
A Eden Evins
Corinne Cather
Melissa A Culhane
Alan Birnbaum
Jonathan Horowitz
Elaine Hsieh
David C Henderson
David A Schoenfeld